Kristen K. White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristen K. White has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Grushow
Department of Chemistry, Biochemistry & Physics, Rider University, Lawrenceville, New Jersey 08648, United States
2 shared publications - Alex Edward Powers
Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
1 shared publication - Brian Button
Marsico Lung Institute
1 shared publication - Cameron Bradley Morrison
Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
1 shared publication - Camille Ehre
Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
1 shared publication - Colby H. Wagner
University of North Carolina at Chapel Hill 1 Department of Cell Biology and Physiology Chapel Hill, NC
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 9 February 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (4)
APOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size
The E4 variant of APOE strongly predisposes individuals to late-onset Alzheimer’s disease. We demonstrate that in response to lipogenesis, apolipoprotein E (APOE) in astrocytes can avoid translocation into the endoplasmic reticulum (ER) lumen and traffic to lipid droplets (LDs) via membrane bridges at ER–LD contacts. APOE knockdown promotes fewer, larger LDs after a fatty acid pulse, which contain more unsaturated triglyceride after fatty acid pulse-chase. This LD size phenotype was rescued by chimeric APOE that targets only LDs. Like APOE depletion, APOE4-expressing astrocytes form a small number of large LDs enriched in unsaturated triglyceride. Additionally, the LDs in APOE4 cells exhibit impaired turnover and increased sensitivity to lipid peroxidation. Our data indicate that APOE plays a previously unrecognized role as an LD surface protein that regulates LD size and composition. APOE4 causes aberrant LD composition and morphology. Our study contributes to accumulating evidence that APOE4 astrocytes with large, unsaturated LDs are sensitized to lipid peroxidation, which could contribute to Alzheimer’s disease risk.
- 9 February 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (4)
Top Cited PapersOpen AccessAPOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size
The E4 variant of APOE strongly predisposes individuals to late-onset Alzheimer’s disease. We demonstrate that in response to lipogenesis, apolipoprotein E (APOE) in astrocytes can avoid translocation into the endoplasmic reticulum (ER) lumen and traffic to lipid droplets (LDs) via membrane bridges at ER–LD contacts. APOE knockdown promotes fewer, larger LDs after a fatty acid pulse, which contain more unsaturated triglyceride after fatty acid pulse-chase. This LD size phenotype was rescued by chimeric APOE that targets only LDs. Like APOE depletion, APOE4-expressing astrocytes form a small number of large LDs enriched in unsaturated triglyceride. Additionally, the LDs in APOE4 cells exhibit impaired turnover and increased sensitivity to lipid peroxidation. Our data indicate that APOE plays a previously unrecognized role as an LD surface protein that regulates LD size and composition. APOE4 causes aberrant LD composition and morphology. Our study contributes to accumulating evidence that APOE4 astrocytes with large, unsaturated LDs are sensitized to lipid peroxidation, which could contribute to Alzheimer’s disease risk.
- Open Access
- 1 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (13) , eabm9718
Mucus concentration–dependent biophysical abnormalities unify submucosal gland and superficial airway dysfunction in cystic fibrosis
Cystic fibrosis (CF) is characterized by abnormal transepithelial ion transport. However, a description of CF lung disease pathophysiology unifying superficial epithelial and submucosal gland (SMG) dysfunctions has remained elusive. We hypothesized that biophysical abnormalities associated with CF mucus hyperconcentration provide a unifying mechanism. Studies of the anion secretion–inhibited pig airway model of CF revealed elevated SMG mucus concentrations, osmotic pressures, and SMG mucus accumulation. Human airway studies revealed hyperconcentrated CF SMG mucus with raised osmotic pressures and cohesive forces predicted to limit SMG mucus secretion/release. Using proline-rich protein 4 (PRR4) as a biomarker of SMG secretion, CF sputum proteomics analyses revealed markedly lower PRR4 levels compared to healthy and bronchiectasis controls, consistent with a failure of CF SMGs to secrete mucus onto airway surfaces. Raised mucus osmotic/cohesive forces, reflecting mucus hyperconcentration, provide a unifying mechanism that describes disease-initiating mucus accumulation on airway surfaces and in SMGs of the CF lung.
- 1 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (13) , eabm9718
Open AccessMucus concentration–dependent biophysical abnormalities unify submucosal gland and superficial airway dysfunction in cystic fibrosis
Cystic fibrosis (CF) is characterized by abnormal transepithelial ion transport. However, a description of CF lung disease pathophysiology unifying superficial epithelial and submucosal gland (SMG) dysfunctions has remained elusive. We hypothesized that biophysical abnormalities associated with CF mucus hyperconcentration provide a unifying mechanism. Studies of the anion secretion–inhibited pig airway model of CF revealed elevated SMG mucus concentrations, osmotic pressures, and SMG mucus accumulation. Human airway studies revealed hyperconcentrated CF SMG mucus with raised osmotic pressures and cohesive forces predicted to limit SMG mucus secretion/release. Using proline-rich protein 4 (PRR4) as a biomarker of SMG secretion, CF sputum proteomics analyses revealed markedly lower PRR4 levels compared to healthy and bronchiectasis controls, consistent with a failure of CF SMGs to secrete mucus onto airway surfaces. Raised mucus osmotic/cohesive forces, reflecting mucus hyperconcentration, provide a unifying mechanism that describes disease-initiating mucus accumulation on airway surfaces and in SMGs of the CF lung.
- Open Access
- 21 April 2020
- Published by American Chemical Society (ACS)
Computational study of hydrogen-bonded lactam dimers
- 21 April 2020
- Published by American Chemical Society (ACS)
Open AccessComputational study of hydrogen-bonded lactam dimers
- Open Access
- 21 April 2020
- Published by American Chemical Society (ACS)
Computational study of hydrogen-bonded lactam dimers
- 21 April 2020
- Published by American Chemical Society (ACS)
Open AccessComputational study of hydrogen-bonded lactam dimers